CKD BiO is a South Korean contract development and manufacturing organization specializing in APIs and intermediates at its cGMP facility approved by US and EU authorities. The company has over 1,500 m3 of fermentation capacity ranging from 12 m3 to 100 m3 scale, with expertise across a broad spectrum of microorganisms including streptomyces, fungi, bacteria, and yeast, supported by decades of accumulated know-how in fermentation-based API manufacturing.
Fermentation-based API manufacturing, cGMP APIs and intermediates, microbial fermentation
1 site worldwide
Involvement in 1 clinical trial
No reviews available yet.
No documents available.